Zobrazeno 1 - 10
of 4 032
pro vyhledávání: '"Hand-Foot Syndrome"'
Autor:
Wanichtanom L; Department of Medical Oncology, Vajira Hospital, Navamindradhiraj University, Thailand., Vrakornvoravuti G; Department of Medical Oncology, Vajira Hospital, Navamindradhiraj University, Thailand., Boonsiri M; Department of Medical Dermatology, Vajira Hospital, Navamindradhiraj University, Thailand., Suthepwanon A; Department of Medical Oncology, Vajira Hospital, Navamindradhiraj University, Thailand.
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2024 Jun 01; Vol. 25 (6), pp. 2203-2210. Date of Electronic Publication: 2024 Jun 01.
Autor:
Minaldi E; Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Via Paradisa, Pisa, Italy., Cappagli V; Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Via Paradisa, Pisa, Italy., Lorusso L; Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Via Paradisa, Pisa, Italy., Valerio L; Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Via Paradisa, Pisa, Italy., Giani C; Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Via Paradisa, Pisa, Italy., Viglione M; Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Via Paradisa, Pisa, Italy., Agate L; Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Via Paradisa, Pisa, Italy., Molinaro E; Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Via Paradisa, Pisa, Italy., Matrone A; Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Via Paradisa, Pisa, Italy., Elisei R; Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Via Paradisa, Pisa, Italy.
Publikováno v:
European thyroid journal [Eur Thyroid J] 2024 Jul 29; Vol. 13 (4). Date of Electronic Publication: 2024 Jul 29 (Print Publication: 2024).
Autor:
Ono K; Division of Cancer Genome and Pharmacotherapy, Department of Clinical Pharmacy, Showa University School of Pharmacy, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan., Murase R; Division of Cancer Genome and Pharmacotherapy, Department of Clinical Pharmacy, Showa University School of Pharmacy, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan., Matsumoto N; Division of Cancer Genome and Pharmacotherapy, Department of Clinical Pharmacy, Showa University School of Pharmacy, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan., Kubota Y; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan., Ishida H; Division of Medical Oncology, Showa University Northern Yokohama Hospital, 35-1 Chigasakichuo, Tsuzuki-ku, Yokohama, 224-8503, Japan., Fujita KI; Division of Cancer Genome and Pharmacotherapy, Department of Clinical Pharmacy, Showa University School of Pharmacy, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan. k.fujita@med.showa-u.ac.jp.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2024 Jul; Vol. 94 (1), pp. 57-66. Date of Electronic Publication: 2024 Mar 08.
Autor:
Saito Y; Department of Clinical Pharmaceutics & Therapeutics, Faculty of Pharmaceutical Sciences, Hokkaido University of Science, 4-1, Maeda 7-jo 15-chome, Teine-ku, Sapporo, Hokkaido, 006-8585, Japan. saito-yo@hus.ac.jp., Takekuma Y; Department of Pharmacy, Hokkaido University Hospital, Kita 14-jo, Nishi 5-chome, Kita-ku, Sapporo, 060-8648, Japan., Takahashi M; Department of Breast Surgery, Hokkaido University Hospital, Kita 14-jo, Nishi 5-chome, Kita-ku, Sapporo, 060-8648, Japan., Oshino T; Department of Breast Surgery, Hokkaido University Hospital, Kita 14-jo, Nishi 5-chome, Kita-ku, Sapporo, 060-8648, Japan., Sugawara M; Department of Pharmacy, Hokkaido University Hospital, Kita 14-jo, Nishi 5-chome, Kita-ku, Sapporo, 060-8648, Japan.; Laboratory of Pharmacokinetics, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita 12-Jo, Nishi 6-chome, Kita-ku, Sapporo, 060-0812, Japan.
Publikováno v:
Scientific reports [Sci Rep] 2024 Jun 18; Vol. 14 (1), pp. 14083. Date of Electronic Publication: 2024 Jun 18.
Autor:
Tahara Y; Department of Health Promotion in Nursing and Midwifery, Graduate School of Nursing, Chiba University, Chiba, Japan. Electronic address: taharayk@chiba-u.jp., Amemiya A; Department of Health Promotion in Nursing and Midwifery, Graduate School of Nursing, Chiba University, Chiba, Japan., Kase R; Department of Health Promotion in Nursing and Midwifery, Graduate School of Nursing, Chiba University, Chiba, Japan., Kitagawa Y; Department of Health Promotion in Nursing and Midwifery, Graduate School of Nursing, Chiba University, Chiba, Japan., Ogasawara S; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan., Kato N; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan., Komiyama M; Department of Health Promotion in Nursing and Midwifery, Graduate School of Nursing, Chiba University, Chiba, Japan.
Publikováno v:
European journal of oncology nursing : the official journal of European Oncology Nursing Society [Eur J Oncol Nurs] 2024 Jun; Vol. 70, pp. 102576. Date of Electronic Publication: 2024 Mar 27.
Autor:
Takano-Mochizuki M; Global Drug Safety, Biopharmaceutical Assessment Unit, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan; Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, Ibaraki 305-8577, Japan. Electronic address: m2-mochizuki@hhc.eisai.co.jp., Nakajima K; Global Drug Safety, Biopharmaceutical Assessment Unit, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan. Electronic address: k7-nakajima@hhc.eisai.co.jp., Ishida T; Global Drug Metabolism and Pharmacokinetics, Biopharmaceutical Assessment Unit, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan. Electronic address: t6-ishida@hhc.eisai.co.jp., Ohta E; Global Drug Safety, Biopharmaceutical Assessment Unit, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan. Electronic address: e2-ota@hhc.eisai.co.jp., Moriyama T; Global Drug Safety, Biopharmaceutical Assessment Unit, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan. Electronic address: t4-moriyama@hhc.eisai.co.jp., Asakura S; Global Drug Safety, Biopharmaceutical Assessment Unit, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan. Electronic address: s-asakura@hhc.eisai.co.jp.
Publikováno v:
Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2024 Jun; Vol. 487, pp. 116977. Date of Electronic Publication: 2024 May 22.
Autor:
Naeem SS; Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India. Electronic address: syedshariq1@gmail.com., Gupta P; Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India., Sahoo RK; Department of Medical Oncology, Dr. B.R.A. Institute-Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India., Kumar VL; Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India., Velpandian T; Ocular Pharmacology, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India., Singh A; Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India., Batra A; Department of Medical Oncology, Dr. B.R.A. Institute-Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India., Pramanik R; Department of Medical Oncology, Dr. B.R.A. Institute-Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India., Rastogi S; Department of Medical Oncology, Dr. B.R.A. Institute-Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India., Srivastava S; Ocular Pharmacology, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Publikováno v:
Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Jun; Vol. 22 (3), pp. 102073. Date of Electronic Publication: 2024 Mar 13.
Autor:
Ugurel S; Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Essen, 45122, Essen, Deutschland., Pföhler C; Klinik für Dermatologie, Venerologie und Allergologie, Univ.-Klinikum des Saarlandes, 66421, Homburg/Saar, Deutschland. claudia.pfoehler@uks.eu., Gutzmer R; Universitäts-Klinik für Dermatologie, Venerologie, Allergologie und Phlebologie, Johannes Wesling Klinikum Minden, Minden, Deutschland, 32427.
Publikováno v:
Dermatologie (Heidelberg, Germany) [Dermatologie (Heidelb)] 2024 Jun; Vol. 75 (6), pp. 451-458. Date of Electronic Publication: 2024 May 27.
Autor:
King TL; Clinical Research Centre, Sarawak General Hospital, Ministry of Health, Kuching, Sarawak, Malaysia.; School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia., Voon PJ; Department of Radiotherapy, Oncology and Palliative Care, Sarawak General Hospital, Ministry of Health, Kuching, Sarawak, Malaysia., Yuen KH; School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia., Mohamed Noor DA; School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia. dzulazri@usm.my.
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 May 14; Vol. 32 (6), pp. 345. Date of Electronic Publication: 2024 May 14.
Autor:
Hirakata M; Pharmaceutical Research Laboratories, Toray Industries, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa 248-8555, Japan., Tomikawa E; Pharmaceutical Research Laboratories, Toray Industries, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa 248-8555, Japan., Sakai C; Pharmaceutical Research Laboratories, Toray Industries, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa 248-8555, Japan., Uchida M; Pharmaceutical Research Laboratories, Toray Industries, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa 248-8555, Japan., Okano T; Pharmaceutical Research Laboratories, Toray Industries, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa 248-8555, Japan., Shimozono R; Pharmaceutical Research Laboratories, Toray Industries, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa 248-8555, Japan., Kawai M; Department of Bio Research, Kamakura Techno-Science, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa, 248-0036, Japan., Itaba S; Department of Bio Research, Kamakura Techno-Science, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa, 248-0036, Japan., Munakata L; Laboratory of Drug and Gene Delivery Research, Faculty of Pharma-Science, Teikyo University, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8605, Japan., Suzuki R; Laboratory of Drug and Gene Delivery Research, Faculty of Pharma-Science, Teikyo University, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8605, Japan., Oshida K; Pharmaceutical Research Laboratories, Toray Industries, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa 248-8555, Japan.. Electronic address: keiyu.oshida.h5@mail.toray.
Publikováno v:
Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2024 Apr; Vol. 485, pp. 116912. Date of Electronic Publication: 2024 Mar 22.